[ORGANIZATION]
Central Drugs Standard Control Organisation
Featured in 3 tracked stories · first seen
Situations
Leqembi Alzheimer’s drug approvals
2 clusters · 2 sources · last updated
Latest: Eisai launches Leqembi in India, introducing first disease-modifying Alzheimer’s treatment
In July 2026 the U.S. Food and Drug Administration cleared a subcutaneous, at‑home starter dose of Leqembi (lecanemab), allowing patients or caregivers to administer the first injection outside a clinic. The approval was
Also covered in
-
India's Narcotics Control Bureau warns of rising chemsex trend among youth
[HEALTH] · 7 sources ·
-
India cracks down on high‑risk drug manufacturers and medical stores
[HEALTH] · 3 sources ·